6MQE
Vaccine-elicited NHP FP-targeting HIV neutralizing antibody DFPH-a.15 in complex with HIV fusion peptide (residue 512-519)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 22-ID |
Synchrotron site | APS |
Beamline | 22-ID |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2018-02-01 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 1 |
Spacegroup name | C 2 2 21 |
Unit cell lengths | 71.234, 147.729, 172.711 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 37.276 - 2.459 |
R-factor | 0.1947 |
Rwork | 0.192 |
R-free | 0.24460 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5i8e |
RMSD bond length | 0.008 |
RMSD bond angle | 1.150 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | PHENIX ((1.12_2829: ???)) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 50.000 | 50.000 | 2.540 |
High resolution limit [Å] | 2.500 | 6.780 | 2.500 |
Rmerge | 0.192 | 0.094 | 0.673 |
Rmeas | 0.210 | 0.103 | 0.770 |
Rpim | 0.085 | 0.042 | 0.368 |
Total number of observations | 187244 | ||
Number of reflections | 32861 | 1760 | 1588 |
<I/σ(I)> | 4.1 | ||
Completeness [%] | 99.7 | 98.2 | 98.5 |
Redundancy | 5.7 | 5.9 | 3.9 |
CC(1/2) | 0.993 | 0.773 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293 | 25% w/v PEG 400, 0.1 M MgCl2, 0.1 M Tris HCl, and 20% w/v PEG 3350 |